Truffle Capital announces the first closing of its new BioMedTech venture fund, dedicated to medical devices and biotechnology

January 10, 2018

ALSO TO BE DISCOVERED

May 17, 2017

Truffle Capital announces the close of Symetis acquisition for $435 million by Boston Scientific

June 24, 2016

Interview of Alexandre Ouimet-Storrs, Partner at Truffle Capital at ASUW16 - Investing in Clean Energy Tech

May 31, 2016

"Growing sustainably à la française", by Philippe Pouletty, Partner at Truffle Capital

April 29, 2016

French software boom built on SaaS

January 13, 2025

Caranx Medical announces FDA submission of TAVIPILOT Soft

November 18, 2024

Un VC français accède à Wyden

November 17, 2024

Philippe Pouletty, CEO and co-founder of Truffle Capital, is a guest on Figaro TV

November 14, 2024

Truffle Capital Leads Wyden’s Series B Funding Round

October 24, 2024

HONG KONG FINTECH WEEK

October 24, 2024

Alan, Swile et Ledger ont été les champions des fintech françaises en 2022